Position in GILD
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$36,012,929
+$3,666,275 QoQ
Shares Held
258,398
-2.0% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,341,272,655 across 18 Drug Manufacturers - General names. GILD ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,276,418 | $312,007,615 | |
| 2 | LLY |
ELI LILLY & Co
|
303,295 | $278,961,642 | |
| 3 | ABBV |
AbbVie Inc.
|
1,000,714 | $217,645,287 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,222,577 | $147,063,787 | |
| 5 | AMGN |
Amgen Inc
|
319,923 | $112,564,907 | |
| 6 | PFE |
Pfizer Inc
|
3,488,515 | $97,957,501 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
992,662 | $60,204,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
258,398 | $36,012,929 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,012,929 | 258,398 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $32,346,654 | 263,538 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $34,365,156 | 309,596 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $39,006,061 | 351,818 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $42,886,913 | 382,748 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $28,684,117 | 310,535 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $27,165,501 | 324,016 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $24,476,068 | 356,742 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $24,966,676 | 340,842 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $30,172,336 | 372,452 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $24,722,556 | 329,898 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $26,712,462 | 346,600 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $28,320,481 | 341,334 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $27,613,309 | 321,646 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $20,190,458 | 327,289 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,286,636 | 312,031 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $18,462,792 | 310,560 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $21,697,174 | 298,818 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $22,761,879 | 325,868 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $22,546,554 | 327,426 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $21,702,366 | 335,794 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $20,098,767 | 344,984 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $23,023,529 | 364,354 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $28,674,076 | 372,681 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $21,189,451 | 283,433 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||